{
  "DOI": "10.1186/s40246-022-00447-3",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-022-00447-3",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\u003cjats:title\u003eBackground\u003c/jats:title\u003e\u003cjats:p\u003eGermline mutations of breast cancer susceptibility gene\u003cjats:italic\u003eBRCA1\u003c/jats:italic\u003eand\u003cjats:italic\u003eBRCA2\u003c/jats:italic\u003e(\u003cjats:italic\u003egBRCA1/2\u003c/jats:italic\u003e) are associated with elevated risk of breast cancer in young women in Asia. BRCA1 and BRCA2 proteins contribute to genomic stability through homologous recombination (HR)-mediated double-strand DNA break repair in cooperation with other HR-related proteins. In this study, we analyzed the targeted sequencing data of Korean breast cancer patients with\u003cjats:italic\u003egBRCA1/2\u003c/jats:italic\u003emutations to investigate the alterations in HR-related genes and their clinical implications.\u003c/jats:p\u003e\u003c/jats:sec\u003e\u003cjats:sec\u003e\u003cjats:title\u003eMaterials and methods\u003c/jats:title\u003e\u003cjats:p\u003eData of the breast cancer patients with pathogenic\u003cjats:italic\u003egBRCA1/2\u003c/jats:italic\u003emutations and qualified targeted next-generation sequencing, SNUH FiRST cancer panel, were analyzed. Single nucleotide polymorphisms, small insertions, and deletions were analyzed with functional annotations using ANNOVAR. HR-related genes were defined as\u003cjats:italic\u003eABL1, ATM, ATR, BARD1, BRCA1, BRCA2, CDKN1A, CDKN2A, CHEK1, CHEK2, FANCA, FANCD2, FANCG, FANCI, FANCL, KDR, MUTYH, PALB2, POLE, POLQ, RAD50, RAD51, RAD51D, RAD54L,\u003c/jats:italic\u003eand\u003cjats:italic\u003eTP53\u003c/jats:italic\u003e. Mismatch-repair genes were\u003cjats:italic\u003eMLH1, MSH2\u003c/jats:italic\u003e, and\u003cjats:italic\u003eMSH6\u003c/jats:italic\u003e. Clinical data were analyzed with cox proportional hazard models and survival analyses.\u003c/jats:p\u003e\u003c/jats:sec\u003e\u003cjats:sec\u003e\u003cjats:title\u003eResults\u003c/jats:title\u003e\u003cjats:p\u003eFifty-five Korean breast cancer patients with known\u003cjats:italic\u003egBRCA1/2\u003c/jats:italic\u003emutations and qualified targeted NGS data were analyzed. Ethnically distinct mutations in\u003cjats:italic\u003egBRCA1/2\u003c/jats:italic\u003egenes were noted, with higher frequencies of Val1833Ser (14.8%), Glu1210Arg (11.1%), and Tyr130Ter (11.1%) in\u003cjats:italic\u003egBRCA1\u003c/jats:italic\u003eand Arg2494Ter (25.0%) and Lys467Ter (14.3%) in\u003cjats:italic\u003egBRCA2.\u003c/jats:italic\u003eConsidering subtypes,\u003cjats:italic\u003egBRCA1\u003c/jats:italic\u003emutations were associated with triple-negative breast cancers (TNBC), while\u003cjats:italic\u003egBRCA2\u003c/jats:italic\u003emutations were more likely hormone receptor-positive breast cancers. At least one missense mutation of HR-related genes was observed in 44 cases (80.0%). The most frequently co-mutated gene was\u003cjats:italic\u003eTP53\u003c/jats:italic\u003e(38.1%). In patients with\u003cjats:italic\u003egBRCA1/2\u003c/jats:italic\u003emutations, however, genetic variations of\u003cjats:italic\u003eTP53\u003c/jats:italic\u003eoccurred in locations different from the known hotspots of those with sporadic breast cancers. The patients with both\u003cjats:italic\u003egBRCA1/2\u003c/jats:italic\u003eand\u003cjats:italic\u003eTP53\u003c/jats:italic\u003emutations were more likely to have TNBC, high Ki-67 values, and increased genetic mutations, especially of HR-related genes. Survival benefit was observed in the\u003cjats:italic\u003eTP53\u003c/jats:italic\u003emutants of patients with\u003cjats:italic\u003egBRCA2\u003c/jats:italic\u003emutations, compared to those with\u003cjats:italic\u003eTP53\u003c/jats:italic\u003ewild types.\u003c/jats:p\u003e\u003c/jats:sec\u003e\u003cjats:sec\u003e\u003cjats:title\u003eConclusion\u003c/jats:title\u003e\u003cjats:p\u003eOur study showed genetic heterogeneity of breast cancer patients with\u003cjats:italic\u003egBRCA1\u003c/jats:italic\u003eand\u003cjats:italic\u003egBRCA2\u003c/jats:italic\u003emutations in the Korean populations. Further studies on precision medicine are needed for tailored treatments of patients with genetic diversity among different ethnic groups.\u003c/jats:p\u003e\u003c/jats:sec\u003e",
  "alternative-id": [
    "447"
  ],
  "article-number": "2",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "25 September 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "19 December 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "6 January 2023"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethical approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The study was approved by the Seoul National University Hospital (SNUH) Institutional Review Board (IRB No. H1509-047-702). Written informed consents were obtained from all participants before study. Clinical data were anonymized and de-identified before analysis."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "The authors declare that they have no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Kim",
      "given": "Jinyong",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Jeong",
      "given": "Kyeonghun",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Jun",
      "given": "Hyeji",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kim",
      "given": "Kwangsoo",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bae",
      "given": "Jeong Mo",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Song",
      "given": "Myung Geun",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Yi",
      "given": "Hanbaek",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Park",
      "given": "Songyi",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Woo",
      "given": "Go-un",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lee",
      "given": "Dae-Won",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kim",
      "given": "Tae-Yong",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lee",
      "given": "Kyung-Hun",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Im",
      "given": "Seock-Ah",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        1,
        6
      ]
    ],
    "date-time": "2023-01-06T04:34:34Z",
    "timestamp": 1672979674000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        12,
        4
      ]
    ],
    "date-time": "2023-12-04T03:56:24Z",
    "timestamp": 1701662184000
  },
  "funder": [
    {
      "DOI": "10.13039/501100003710",
      "award": [
        "HI14C1277"
      ],
      "doi-asserted-by": "crossref",
      "name": "Korea Health Industry Development Institute"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        19
      ]
    ],
    "date-time": "2024-04-19T16:05:58Z",
    "timestamp": 1713542758591
  },
  "is-referenced-by-count": 5,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2023,
        1,
        6
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2023,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            1,
            6
          ]
        ],
        "date-time": "2023-01-06T00:00:00Z",
        "timestamp": 1672963200000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            1,
            6
          ]
        ],
        "date-time": "2023-01-06T00:00:00Z",
        "timestamp": 1672963200000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-022-00447-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-022-00447-3/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-022-00447-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2023,
        1,
        6
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2023,
        1,
        6
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1126/science.1251827",
      "author": "FJ Couch",
      "doi-asserted-by": "publisher",
      "first-page": "1466",
      "issue": "6178",
      "journal-title": "Science",
      "key": "447_CR1",
      "unstructured": "Couch FJ, Nathanson KL, Offit K. Two decades after BRCA: setting paradigms in personalized cancer care and prevention. Science. 2014;343(6178):1466–70.",
      "volume": "343",
      "year": "2014"
    },
    {
      "DOI": "10.1126/science.1251900",
      "author": "MC King",
      "doi-asserted-by": "publisher",
      "first-page": "1462",
      "issue": "6178",
      "journal-title": "Science",
      "key": "447_CR2",
      "unstructured": "King MC. “The race” to clone BRCA1. Science. 2014;343(6178):1462–5.",
      "volume": "343",
      "year": "2014"
    },
    {
      "DOI": "10.1038/s41467-017-00921-w",
      "author": "N Riaz",
      "doi-asserted-by": "publisher",
      "first-page": "857",
      "issue": "1",
      "journal-title": "Nat Commun",
      "key": "447_CR3",
      "unstructured": "Riaz N, et al. Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes. Nat Commun. 2017;8(1):857.",
      "volume": "8",
      "year": "2017"
    },
    {
      "DOI": "10.1111/j.1399-0004.2006.00717.x",
      "author": "SH Han",
      "doi-asserted-by": "publisher",
      "first-page": "496",
      "issue": "6",
      "journal-title": "Clin Genet",
      "key": "447_CR4",
      "unstructured": "Han SH, et al. Mutation analysis of BRCA1 and BRCA2 from 793 Korean patients with sporadic breast cancer. Clin Genet. 2006;70(6):496–501.",
      "volume": "70",
      "year": "2006"
    },
    {
      "DOI": "10.4132/jptm.2020.04.07",
      "author": "E-K Kim",
      "doi-asserted-by": "publisher",
      "first-page": "265",
      "issue": "4",
      "journal-title": "J Pathol Transl Med",
      "key": "447_CR5",
      "unstructured": "Kim E-K, Park SY, Kim S-W. Clinicopathological characteristics of BRCA-associated breast cancer in Asian patients. J Pathol Transl Med. 2020;54(4):265–75.",
      "volume": "54",
      "year": "2020"
    },
    {
      "DOI": "10.4048/jbc.2013.16.4.357",
      "author": "H Kim",
      "doi-asserted-by": "publisher",
      "first-page": "357",
      "issue": "4",
      "journal-title": "J Breast Cancer",
      "key": "447_CR6",
      "unstructured": "Kim H, Choi DH. Distribution of BRCA1 and BRCA2 mutations in asian patients with breast cancer. J Breast Cancer. 2013;16(4):357–65.",
      "volume": "16",
      "year": "2013"
    },
    {
      "DOI": "10.1002/ijc.30692",
      "author": "G-T Lang",
      "doi-asserted-by": "publisher",
      "first-page": "129",
      "issue": "1",
      "journal-title": "Int J Cancer",
      "key": "447_CR7",
      "unstructured": "Lang G-T, et al. The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next-generation sequencing. Int J Cancer. 2017;141(1):129–42.",
      "volume": "141",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41523-019-0117-7",
      "author": "M Abubakar",
      "doi-asserted-by": "publisher",
      "first-page": "20",
      "issue": "1",
      "journal-title": "NPJ Breast Cancer",
      "key": "447_CR8",
      "unstructured": "Abubakar M, et al. Clinicopathological and epidemiological significance of breast cancer subtype reclassification based on p53 immunohistochemical expression. NPJ Breast Cancer. 2019;5(1):20.",
      "volume": "5",
      "year": "2019"
    },
    {
      "DOI": "10.1186/bcr2780",
      "author": "AW Kurian",
      "doi-asserted-by": "publisher",
      "first-page": "R99",
      "issue": "6",
      "journal-title": "Breast Cancer Res",
      "key": "447_CR9",
      "unstructured": "Kurian AW, et al. Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. Breast Cancer Res. 2010;12(6):R99.",
      "volume": "12",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nature10760",
      "author": "CJ Lord",
      "doi-asserted-by": "publisher",
      "first-page": "287",
      "issue": "7381",
      "journal-title": "Nature",
      "key": "447_CR10",
      "unstructured": "Lord CJ, Ashworth A. The DNA damage response and cancer therapy. Nature. 2012;481(7381):287–94.",
      "volume": "481",
      "year": "2012"
    },
    {
      "DOI": "10.1101/cshperspect.a016600",
      "author": "R Prakash",
      "doi-asserted-by": "publisher",
      "issue": "4",
      "journal-title": "Cold Spring Harb Perspect Biol",
      "key": "447_CR11",
      "unstructured": "Prakash R, et al. Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins. Cold Spring Harb Perspect Biol. 2015;7(4): a016600.",
      "volume": "7",
      "year": "2015"
    },
    {
      "DOI": "10.1016/S0092-8674(00)81847-4",
      "author": "R Scully",
      "doi-asserted-by": "publisher",
      "first-page": "265",
      "issue": "2",
      "journal-title": "Cell",
      "key": "447_CR12",
      "unstructured": "Scully R, et al. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell. 1997;88(2):265–75.",
      "volume": "88",
      "year": "1997"
    },
    {
      "DOI": "10.1038/386804a0",
      "author": "SK Sharan",
      "doi-asserted-by": "publisher",
      "first-page": "804",
      "issue": "6627",
      "journal-title": "Nature",
      "key": "447_CR13",
      "unstructured": "Sharan SK, et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature. 1997;386(6627):804–10.",
      "volume": "386",
      "year": "1997"
    },
    {
      "DOI": "10.1038/ng1296-430",
      "author": "LC Wu",
      "doi-asserted-by": "publisher",
      "first-page": "430",
      "issue": "4",
      "journal-title": "Nat Genet",
      "key": "447_CR14",
      "unstructured": "Wu LC, et al. Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat Genet. 1996;14(4):430–40.",
      "volume": "14",
      "year": "1996"
    },
    {
      "DOI": "10.1016/j.molcel.2006.05.022",
      "author": "B Xia",
      "doi-asserted-by": "publisher",
      "first-page": "719",
      "issue": "6",
      "journal-title": "Mol Cell",
      "key": "447_CR15",
      "unstructured": "Xia B, et al. Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell. 2006;22(6):719–29.",
      "volume": "22",
      "year": "2006"
    },
    {
      "DOI": "10.1101/cshperspect.a016451",
      "author": "A Zelensky",
      "doi-asserted-by": "publisher",
      "issue": "12",
      "journal-title": "Cold Spring Harb Perspect Biol",
      "key": "447_CR16",
      "unstructured": "Zelensky A, Kanaar R, Wyman C. Mediators of homologous DNA pairing. Cold Spring Harb Perspect Biol. 2014;6(12): a016451.",
      "volume": "6",
      "year": "2014"
    },
    {
      "DOI": "10.1126/science.aam7344",
      "author": "CJ Lord",
      "doi-asserted-by": "publisher",
      "first-page": "1152",
      "issue": "6330",
      "journal-title": "Science",
      "key": "447_CR17",
      "unstructured": "Lord CJ, Ashworth A. PARP inhibitors: synthetic lethality in the clinic. Science. 2017;355(6330):1152–8.",
      "volume": "355",
      "year": "2017"
    },
    {
      "DOI": "10.1056/NEJMoa1911440",
      "author": "J de Bono",
      "doi-asserted-by": "publisher",
      "first-page": "2091",
      "issue": "22",
      "journal-title": "N Engl J Med",
      "key": "447_CR18",
      "unstructured": "de Bono J, et al. Olaparib for metastatic castration-resistant prostate cancer. N Engl J Med. 2020;382(22):2091–102.",
      "volume": "382",
      "year": "2020"
    },
    {
      "DOI": "10.1056/NEJMoa1910962",
      "author": "A González-Martín",
      "doi-asserted-by": "publisher",
      "first-page": "2391",
      "issue": "25",
      "journal-title": "N Engl J Med",
      "key": "447_CR19",
      "unstructured": "González-Martín A, et al. Niraparib in patients with newly diagnosed advanced ovarian cancer. N Engl J Med. 2019;381(25):2391–402.",
      "volume": "381",
      "year": "2019"
    },
    {
      "DOI": "10.1200/PO.17.00286",
      "author": "AL Heeke",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "journal-title": "JCO Precis Oncol",
      "key": "447_CR20",
      "unstructured": "Heeke AL, et al. Prevalence of homologous recombination-related gene mutations across multiple cancer types. JCO Precis Oncol. 2018;2:1–13.",
      "volume": "2",
      "year": "2018"
    },
    {
      "DOI": "10.1200/JCO.1998.16.5.1642",
      "author": "M Robson",
      "doi-asserted-by": "publisher",
      "first-page": "1642",
      "issue": "5",
      "journal-title": "J Clin Oncol",
      "key": "447_CR21",
      "unstructured": "Robson M, et al. BRCA-associated breast cancer in young women. J Clin Oncol. 1998;16(5):1642–9.",
      "volume": "16",
      "year": "1998"
    },
    {
      "DOI": "10.1038/nm.4292",
      "author": "H Davies",
      "doi-asserted-by": "publisher",
      "first-page": "517",
      "issue": "4",
      "journal-title": "Nat Med",
      "key": "447_CR22",
      "unstructured": "Davies H, et al. HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures. Nat Med. 2017;23(4):517–25.",
      "volume": "23",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s10549-017-4624-7",
      "author": "ML Telli",
      "doi-asserted-by": "publisher",
      "first-page": "625",
      "issue": "3",
      "journal-title": "Breast Cancer Res Treat",
      "key": "447_CR23",
      "unstructured": "Telli ML, et al. Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancer. Breast Cancer Res Treat. 2018;168(3):625–30.",
      "volume": "168",
      "year": "2018"
    },
    {
      "DOI": "10.1186/bcr3670",
      "author": "JA Watkins",
      "doi-asserted-by": "publisher",
      "first-page": "211",
      "issue": "3",
      "journal-title": "Breast Cancer Res",
      "key": "447_CR24",
      "unstructured": "Watkins JA, et al. Genomic scars as biomarkers of homologous recombination deficiency and drug response in breast and ovarian cancers. Breast Cancer Res. 2014;16(3):211.",
      "volume": "16",
      "year": "2014"
    },
    {
      "DOI": "10.3892/mco.2021.2453",
      "author": "K Christofyllakis",
      "doi-asserted-by": "publisher",
      "first-page": "21",
      "issue": "1",
      "journal-title": "Mol Clin Oncol",
      "key": "447_CR25",
      "unstructured": "Christofyllakis K, et al. Cost-effectiveness of precision cancer medicine-current challenges in the use of next generation sequencing for comprehensive tumour genomic profiling and the role of clinical utility frameworks (Review). Mol Clin Oncol. 2022;16(1):21.",
      "volume": "16",
      "year": "2022"
    },
    {
      "DOI": "10.1093/bioinformatics/bty560",
      "author": "S Chen",
      "doi-asserted-by": "publisher",
      "first-page": "i884",
      "issue": "17",
      "journal-title": "Bioinformatics",
      "key": "447_CR26",
      "unstructured": "Chen S, et al. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34(17):i884–90.",
      "volume": "34",
      "year": "2018"
    },
    {
      "DOI": "10.1093/bioinformatics/btp698",
      "author": "H Li",
      "doi-asserted-by": "publisher",
      "first-page": "589",
      "issue": "5",
      "journal-title": "Bioinformatics",
      "key": "447_CR27",
      "unstructured": "Li H, Durbin R. Fast and accurate long-read alignment with Burrows–Wheeler transform. Bioinformatics. 2010;26(5):589–95.",
      "volume": "26",
      "year": "2010"
    },
    {
      "DOI": "10.1038/ng.806",
      "author": "MA DePristo",
      "doi-asserted-by": "publisher",
      "first-page": "491",
      "issue": "5",
      "journal-title": "Nat Genet",
      "key": "447_CR28",
      "unstructured": "DePristo MA, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43(5):491.",
      "volume": "43",
      "year": "2011"
    },
    {
      "author": "GA Van der Auwera",
      "edition": "1",
      "key": "447_CR29",
      "unstructured": "Van der Auwera GA, O’Connor BD, Safari AORMC. Genomics in the cloud : using Docker, GATK, and WDL in Terra. 1st ed. Sebastopol: O’Reilly Media; 2020.",
      "volume-title": "Genomics in the cloud : using Docker, GATK, and WDL in Terra",
      "year": "2020"
    },
    {
      "DOI": "10.1093/nar/gkq603",
      "author": "K Wang",
      "doi-asserted-by": "publisher",
      "issue": "16",
      "journal-title": "Nucleic Acids Res",
      "key": "447_CR30",
      "unstructured": "Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16): e164.",
      "volume": "38",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nature19057",
      "author": "M Lek",
      "doi-asserted-by": "publisher",
      "first-page": "285",
      "issue": "7616",
      "journal-title": "Nature",
      "key": "447_CR31",
      "unstructured": "Lek M, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285–91.",
      "volume": "536",
      "year": "2016"
    },
    {
      "DOI": "10.1038/nature15393",
      "author": "Genomes Project C",
      "doi-asserted-by": "publisher",
      "first-page": "68",
      "issue": "7571",
      "journal-title": "Nature",
      "key": "447_CR32",
      "unstructured": "Genomes Project C, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68–74.",
      "volume": "526",
      "year": "2015"
    },
    {
      "DOI": "10.1038/s41586-020-2308-7",
      "author": "KJ Karczewski",
      "doi-asserted-by": "publisher",
      "first-page": "434",
      "issue": "7809",
      "journal-title": "Nature",
      "key": "447_CR33",
      "unstructured": "Karczewski KJ, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434–43.",
      "volume": "581",
      "year": "2020"
    },
    {
      "DOI": "10.1038/nature11690",
      "author": "WQ Fu",
      "doi-asserted-by": "publisher",
      "first-page": "216",
      "issue": "7431",
      "journal-title": "Nature",
      "key": "447_CR34",
      "unstructured": "Fu WQ, et al. Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature. 2013;493(7431):216–20.",
      "volume": "493",
      "year": "2013"
    },
    {
      "DOI": "10.1002/humu.23035",
      "author": "L Bouaoun",
      "doi-asserted-by": "publisher",
      "first-page": "865",
      "issue": "9",
      "journal-title": "Hum Mutat",
      "key": "447_CR35",
      "unstructured": "Bouaoun L, et al. TP53 variations in human cancers: new lessons from the IARC TP53 database and genomics data. Hum Mutat. 2016;37(9):865–76.",
      "volume": "37",
      "year": "2016"
    },
    {
      "DOI": "10.1101/gr.239244.118",
      "author": "A Mayakonda",
      "doi-asserted-by": "publisher",
      "first-page": "1747",
      "issue": "11",
      "journal-title": "Genome Res",
      "key": "447_CR36",
      "unstructured": "Mayakonda A, et al. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747–56.",
      "volume": "28",
      "year": "2018"
    },
    {
      "DOI": "10.1155/S1110724302204052",
      "author": "AJ Bishop",
      "doi-asserted-by": "publisher",
      "first-page": "75",
      "issue": "2",
      "journal-title": "J Biomed Biotechnol",
      "key": "447_CR37",
      "unstructured": "Bishop AJ, Schiestl RH. Homologous recombination and its role in carcinogenesis. J Biomed Biotechnol. 2002;2(2):75–85.",
      "volume": "2",
      "year": "2002"
    },
    {
      "key": "447_CR38",
      "unstructured": "Kassambara A, Biecek KMP, Fabian S. Survminer: drawing survival curves using ‘ggplot2’ 2021. Available from: https://CRAN.R-project.org/package=survminer."
    },
    {
      "DOI": "10.1007/s11568-010-9136-z",
      "author": "A Kwong",
      "doi-asserted-by": "publisher",
      "first-page": "63",
      "issue": "1",
      "journal-title": "HUGO J",
      "key": "447_CR39",
      "unstructured": "Kwong A, et al. Clinical and pathological characteristics of Chinese patients with BRCA related breast cancer. HUGO J. 2009;3(1):63–76.",
      "volume": "3",
      "year": "2009"
    },
    {
      "DOI": "10.1002/(SICI)1097-0142(19960215)77:4\u003c697::AID-CNCR16\u003e3.0.CO;2-W",
      "author": "JN Marcus",
      "doi-asserted-by": "publisher",
      "first-page": "697",
      "issue": "4",
      "journal-title": "Cancer",
      "key": "447_CR40",
      "unstructured": "Marcus JN, et al. Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer. 1996;77(4):697–709.",
      "volume": "77",
      "year": "1996"
    },
    {
      "DOI": "10.1038/s41598-020-63759-1",
      "author": "S De Talhouet",
      "doi-asserted-by": "publisher",
      "first-page": "7073",
      "issue": "1",
      "journal-title": "Sci Rep",
      "key": "447_CR41",
      "unstructured": "De Talhouet S, et al. Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes. Sci Rep. 2020;10(1):7073.",
      "volume": "10",
      "year": "2020"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-11-0775",
      "author": "N Mavaddat",
      "doi-asserted-by": "publisher",
      "first-page": "134",
      "issue": "1",
      "journal-title": "Cancer Epidemiol Biomark Prev",
      "key": "447_CR42",
      "unstructured": "Mavaddat N, et al. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the consortium of investigators of modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol Biomark Prev. 2012;21(1):134–47.",
      "volume": "21",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.clon.2010.11.007",
      "author": "SA Han",
      "doi-asserted-by": "publisher",
      "first-page": "434",
      "issue": "7",
      "journal-title": "Clin Oncol",
      "key": "447_CR43",
      "unstructured": "Han SA, et al. The Korean Hereditary Breast Cancer (KOHBRA) Study: protocols and interim report. Clin Oncol. 2011;23(7):434–41.",
      "volume": "23",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s10549-012-2001-0",
      "author": "BH Son",
      "doi-asserted-by": "publisher",
      "first-page": "1143",
      "issue": "3",
      "journal-title": "Breast Cancer Res Treat",
      "key": "447_CR44",
      "unstructured": "Son BH, et al. Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study. Breast Cancer Res Treat. 2012;133(3):1143–52.",
      "volume": "133",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s10549-015-3377-4",
      "author": "E Kang",
      "doi-asserted-by": "publisher",
      "first-page": "157",
      "issue": "1",
      "journal-title": "Breast Cancer Res Treat",
      "key": "447_CR45",
      "unstructured": "Kang E, et al. The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study. Breast Cancer Res Treat. 2015;151(1):157–68.",
      "volume": "151",
      "year": "2015"
    },
    {
      "DOI": "10.1111/j.1349-7006.2008.00944.x",
      "author": "K Sugano",
      "doi-asserted-by": "publisher",
      "first-page": "1967",
      "issue": "10",
      "journal-title": "Cancer Sci",
      "key": "447_CR46",
      "unstructured": "Sugano K, et al. Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer. Cancer Sci. 2008;99(10):1967–76.",
      "volume": "99",
      "year": "2008"
    },
    {
      "DOI": "10.4143/crt.2016.433",
      "author": "JS Park",
      "doi-asserted-by": "publisher",
      "first-page": "1012",
      "issue": "4",
      "journal-title": "Cancer Res Treat",
      "key": "447_CR47",
      "unstructured": "Park JS, et al. Identification of a novel BRCA1 pathogenic mutation in korean patients following reclassification of BRCA1 and BRCA2 variants according to the ACMG standards and guidelines using relevant ethnic controls. Cancer Res Treat. 2017;49(4):1012–21.",
      "volume": "49",
      "year": "2017"
    },
    {
      "author": "E Levy-Lahad",
      "first-page": "1059",
      "issue": "5",
      "journal-title": "Am J Hum Genet",
      "key": "447_CR48",
      "unstructured": "Levy-Lahad E, et al. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Am J Hum Genet. 1997;60(5):1059–67.",
      "volume": "60",
      "year": "1997"
    },
    {
      "DOI": "10.1111/tbj.12392",
      "author": "S Bayraktar",
      "doi-asserted-by": "publisher",
      "first-page": "260",
      "issue": "3",
      "journal-title": "Breast J",
      "key": "447_CR49",
      "unstructured": "Bayraktar S, et al. Genotype-phenotype correlations by ethnicity and mutation location in BRCA mutation carriers. Breast J. 2015;21(3):260–7.",
      "volume": "21",
      "year": "2015"
    },
    {
      "DOI": "10.1186/s12885-022-09181-4",
      "author": "O ElBiad",
      "doi-asserted-by": "publisher",
      "first-page": "208",
      "issue": "1",
      "journal-title": "BMC Cancer",
      "key": "447_CR50",
      "unstructured": "ElBiad O, et al. Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa. BMC Cancer. 2022;22(1):208.",
      "volume": "22",
      "year": "2022"
    },
    {
      "DOI": "10.1200/JCO.2011.41.0027",
      "author": "JN Weitzel",
      "doi-asserted-by": "publisher",
      "first-page": "210",
      "issue": "2",
      "journal-title": "J Clin Oncol",
      "key": "447_CR51",
      "unstructured": "Weitzel JN, et al. Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the Southwestern United States: a report from the clinical cancer genetics community research network. J Clin Oncol. 2012;31(2):210–6.",
      "volume": "31",
      "year": "2012"
    },
    {
      "DOI": "10.1200/JCO.2011.41.0027",
      "author": "JN Weitzel",
      "doi-asserted-by": "publisher",
      "first-page": "210",
      "issue": "2",
      "journal-title": "J Clin Oncol",
      "key": "447_CR52",
      "unstructured": "Weitzel JN, et al. Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network. J Clin Oncol. 2013;31(2):210–6.",
      "volume": "31",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.cancergen.2019.06.006",
      "author": "M Papamentzelopoulou",
      "doi-asserted-by": "publisher",
      "first-page": "90",
      "journal-title": "Cancer Genet",
      "key": "447_CR53",
      "unstructured": "Papamentzelopoulou M, et al. Prevalence and founder effect of the BRCA1 p.(Val1833Met) variant in the Greek population, with further evidence for pathogenicity and risk modification. Cancer Genet. 2019;237:90–6.",
      "volume": "237",
      "year": "2019"
    },
    {
      "DOI": "10.1038/nature17676",
      "author": "S Nik-Zainal",
      "doi-asserted-by": "publisher",
      "first-page": "47",
      "issue": "7605",
      "journal-title": "Nature",
      "key": "447_CR54",
      "unstructured": "Nik-Zainal S, et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature. 2016;534(7605):47–54.",
      "volume": "534",
      "year": "2016"
    },
    {
      "DOI": "10.1101/cshperspect.a001008",
      "author": "M Olivier",
      "doi-asserted-by": "publisher",
      "issue": "1",
      "journal-title": "Cold Spring Harb Perspect Biol",
      "key": "447_CR55",
      "unstructured": "Olivier M, Hollstein M, Hainaut P. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol. 2010;2(1): a001008.",
      "volume": "2",
      "year": "2010"
    },
    {
      "DOI": "10.1126/science.8023157",
      "author": "Y Cho",
      "doi-asserted-by": "publisher",
      "first-page": "346",
      "issue": "5170",
      "journal-title": "Science",
      "key": "447_CR56",
      "unstructured": "Cho Y, et al. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science. 1994;265(5170):346–55.",
      "volume": "265",
      "year": "1994"
    },
    {
      "author": "MS Greenblatt",
      "first-page": "4092",
      "issue": "10",
      "journal-title": "Can Res",
      "key": "447_CR57",
      "unstructured": "Greenblatt MS, et al. TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution. Can Res. 2001;61(10):4092–7.",
      "volume": "61",
      "year": "2001"
    },
    {
      "DOI": "10.1038/sj.onc.1202298",
      "author": "DR Walker",
      "doi-asserted-by": "publisher",
      "first-page": "211",
      "issue": "1",
      "journal-title": "Oncogene",
      "key": "447_CR58",
      "unstructured": "Walker DR, et al. Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features. Oncogene. 1999;18(1):211–8.",
      "volume": "18",
      "year": "1999"
    },
    {
      "DOI": "10.1038/s41418-022-00976-3",
      "author": "KC de Andrade",
      "doi-asserted-by": "publisher",
      "first-page": "1071",
      "issue": "5",
      "journal-title": "Cell Death Differ",
      "key": "447_CR59",
      "unstructured": "de Andrade KC, et al. The TP53 database: transition from the International Agency for Research on Cancer to the US National Cancer Institute. Cell Death Differ. 2022;29(5):1071–3.",
      "volume": "29",
      "year": "2022"
    },
    {
      "DOI": "10.1101/2021.02.18.21251882",
      "doi-asserted-by": "crossref",
      "key": "447_CR60",
      "unstructured": "Takamatsu S, et al. The utility of homologous recombination deficiency biomarkers across cancer types. medRxiv, 2021: p. 2021.02.18.21251882."
    },
    {
      "DOI": "10.1093/annonc/mdz132",
      "author": "K Nones",
      "doi-asserted-by": "publisher",
      "first-page": "1071",
      "issue": "7",
      "journal-title": "Ann Oncol",
      "key": "447_CR61",
      "unstructured": "Nones K, et al. Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers. Ann Oncol. 2019;30(7):1071–9.",
      "volume": "30",
      "year": "2019"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-05-1029",
      "author": "M Olivier",
      "doi-asserted-by": "publisher",
      "first-page": "1157",
      "issue": "4",
      "journal-title": "Clin Cancer Res",
      "key": "447_CR62",
      "unstructured": "Olivier M, et al. The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer. Clin Cancer Res. 2006;12(4):1157–67.",
      "volume": "12",
      "year": "2006"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-13-2943",
      "author": "L Silwal-Pandit",
      "doi-asserted-by": "publisher",
      "first-page": "3569",
      "issue": "13",
      "journal-title": "Clin Cancer Res",
      "key": "447_CR63",
      "unstructured": "Silwal-Pandit L, et al. TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance. Clin Cancer Res. 2014;20(13):3569–80.",
      "volume": "20",
      "year": "2014"
    },
    {
      "DOI": "10.1101/2022.03.31.486643",
      "doi-asserted-by": "crossref",
      "key": "447_CR64",
      "unstructured": "Ragu ME, et al. TP53 somatic mutations in Asian breast cancer are associated with subtype-specific effects. bioRxiv, 2022: p. 2022.03.31.486643."
    },
    {
      "DOI": "10.1158/0008-5472.CAN-08-3426",
      "author": "H Holstege",
      "doi-asserted-by": "publisher",
      "first-page": "3625",
      "issue": "8",
      "journal-title": "Cancer Res",
      "key": "447_CR65",
      "unstructured": "Holstege H, et al. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer. Cancer Res. 2009;69(8):3625–33.",
      "volume": "69",
      "year": "2009"
    },
    {
      "DOI": "10.4174/astr.2020.98.6.291",
      "author": "SY Bae",
      "doi-asserted-by": "publisher",
      "first-page": "291",
      "issue": "6",
      "journal-title": "Ann Surg Treat Res",
      "key": "447_CR66",
      "unstructured": "Bae SY, et al. Differences in prognosis by p53 expression after neoadjuvant chemotherapy in triple-negative breast cancer. Ann Surg Treat Res. 2020;98(6):291–8.",
      "volume": "98",
      "year": "2020"
    }
  ],
  "reference-count": 66,
  "references-count": 66,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-022-00447-3"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "17"
}